Neurogenic abnormalities in masked hypertension

Hypertension

Volumn 50, Issue 3, 2007, Pages 537-542

  Grassi, Guido ^a,b,c,d,f   Seravalle, Gino ^f   Trevano, Fosca Quarti ^a   Dell'Oro, Raffaella ^a   Bolla, Gianbattista ^b,c,d   Cuspidi, Cesare ^e   Arenare, Francesca ^a   Mancia, Giuseppe ^a,b,c,d,f  

^a SAN GERARDO HOSPITAL   (Italy)

^b Centro di Fisiologia Clinica e Ipertensione   (Italy)

^c Centro Interuniversitario di Fisiologia Clinica e Ipertensione   (Italy)

^d Dipartimento di Medicina Interna e Terapia Medica   (Italy)

^e Centro Ipertensione Arteriosa e Prevenzione Cardiovascolare   (Italy)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Baroreflex; Masked hypertension; Sympathetic activity; White coat hypertension

Indexed keywords

INSULIN; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; ANTHROPOMETRY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; HEART BEAT; HEART RATE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; MALE; NEUROLOGIC DISEASE; PERONEUS NERVE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC NERVE; WHITE COAT HYPERTENSION;

BAROREFLEX; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HEART RATE; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PERONEAL NERVE; SYMPATHETIC NERVOUS SYSTEM;

EID: 34548177542     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.092528     Document Type: Article

References (38)

1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
2. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens. 1993;11:647-655.
3. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;311:68-72.
4. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens. 2004;17:217-222.
5. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens. 1989;11:75-89.
6. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension. 2004;43:169-175.
7. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension. 1983;5:86-99.
8. Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A. Twenty-four hour autonomic nervous function in sustained and "white-coat" hypertension. Am Heart J. 2000;140:672-677.
9. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DASG. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol. 2002;40:126-132.
10. Neumann SA, Jennings R, Muldoon MF, Manuck SB. White-coat hypertension and autonomic nervous system dysregulation. Am J Hypertens. 2005;18:584-588.
11. Guidelines Committee. 2003 European Society of Hypertension/European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
12. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564-572.
13. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressioni Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-1392.
14. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen JA. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45:493-498.
15. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Log-term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure. Hypertension. 2006;47:846-853.
16. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-hour ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508-515.
17. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728.
18. Groppelli A, Omboni S, Parati G, Mancia G. Elevation of non-invasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intraarterial blood pressure. Hypertension. 1992;20:227-232.
19. Sega R, Cesana G, Milesi C, Grassi G, Zanchetti A, Mancia G. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension. 1997;30:1-6.
20. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697-701.
21. Grassi G, Bolla GB, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci (Lond). 1997;92:285-289.
22. Mancia G, Mark AL. Arterial baroreflexes in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology, Section 2: The Cardiovascular System. Bethesda, MD: American Physiological Society; 1983:755-793.
23. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979;25:131-138.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
25. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 1977;55:613-618.
26. Strandberg TE, Salomaa V. White-coat effects, blood pressure and mortality in men: a prospective cohort study. Eur Heart J. 2000;21:1714-1718.
27. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White-coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens. 2003;17:811-817.
28. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342-1349.
29. Grassi G, Turri C, Vailati S, Dell'Oro R, Mancia G. Muscle and skin sympathetic nerve traffic during the "white-coat" effect. Circulation. 1999;100:222-255.
30. Mancia G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Grassi G. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease. J Hypertens. 2006;24(suppl 1):S51-S56.
31. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
32. Lembo G, Napoli R, Capaldo B, Rendina V, Iaccarino G, Volpe M, Trimarco B, Sacca L. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest. 1992;90:24-29.
33. Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993;92:147-154.
34. Sowers JR. Insulin resistance and hypertension. Am J Physiol. 2004;286:H1597-H1602.
35. Folkow B, Di Bona GF, Hjemdahl P, Toren PH, Wallin BG. Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension. 1983;5:399-403.
36. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R, Mancia G. Heart rate as marker of sympathetic activity. J Hypertens. 1998;16:1635-1639.
37. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96:3423-3429.
38. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.